Centers
Center for Clean Energy Innovation
Center for Data Innovation
Center for Life Sciences Innovation
Centre for Canadian Innovation and Competitiveness
Hamilton Center on Industrial Strategy
Schumpeter Project on Competition Policy
Issues
Clean Energy Innovation
Innovation & Competitiveness
IT & Data
Life Sciences & Agricultural Biotech
Telecommunications
Trade & Globalization
Regions
Africa
Asia-Pacific
Canada
China
Europe
Latin America
Global
Publications
Reports & Briefings
Commentary
Podcasts
Testimonies & Filings
Books & Edited Volumes
Events
Events
Presentations
News
Press Releases
News Clips
Media Contacts
ITIF Newsletters
About
About ITIF
Staff
Board
Affiliated Experts
Supporters
Jobs
Donate
Op-Art: Drug Price Controls vs. the NIH “Cancer Moonshot” Initiative
By
Robert D. Atkinson
|
February 21, 2022
Editors’ Recommendations
September 9, 2019
The Link Between Drug Prices and Research on the Next Generation of Cures
November 22, 2021
Drug Price Controls Are Bad Policy. Congress Should Instead Double Down on Innovation to Boost Productivity in Biopharma R&D
May 20, 2021
Five Fatal Flaws in Rep. Katie Porter’s Indictment of the U.S. Drug Industry